Patents by Inventor Paul Charles LEVESQUE

Paul Charles LEVESQUE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MINIATURIZED DYSTROPHINS HAVING SPECTRIN FUSION DOMAINS AND USES THEREOF
    Publication number: 20230407331
    Abstract: Disclosed herein are nucleic acid molecules, polypeptides, cells, vectors, and pharmaceutical compositions relating to miniaturized dystrophin. Methods of production and methods of therapeutic use of the miniaturized dystrophin are also disclosed.
    Type: Application
    Filed: November 2, 2022
    Publication date: December 21, 2023
    Inventors: Glen B. Banks, Jonathan Harry Davis, Paul Charles Levesque
  • Miniaturized dystrophins having spectrin fusion domains and uses thereof
    Patent number: 11535868
    Abstract: Disclosed herein are nucleic acid molecules, polypeptides, cells, vectors, and pharmaceutical compositions relating to miniaturized dystrophin. Methods of production and methods of therapeutic use of the miniaturized dystrophin are also disclosed.
    Type: Grant
    Filed: April 28, 2021
    Date of Patent: December 27, 2022
    Assignee: Bristol-Myers Squibb Company
    Inventors: Glen Banks, Jonathan Harry Davis, Paul Charles Levesque
  • MINIATURIZED DYSTROPHINS AND USES THEREOF
    Publication number: 20210403947
    Abstract: Disclosed herein are nucleic acid molecules, polypeptides, cells, vectors, and pharmaceutical compositions relating to miniaturized dystrophin. Methods of production and methods of therapeutic use of the miniaturized dystrophin are also disclosed.
    Type: Application
    Filed: October 24, 2019
    Publication date: December 30, 2021
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Glen BANKS, Jonathan Harry DAVIS, Paul Charles LEVESQUE
  • Miniaturized Dystrophins Having Spectrin Fusion Domains and Uses Thereof
    Publication number: 20210340195
    Abstract: Disclosed herein are nucleic acid molecules, polypeptides, cells, vectors, and pharmaceutical compositions relating to miniaturized dystrophin. Methods of production and methods of therapeutic use of the miniaturized dystrophin are also disclosed.
    Type: Application
    Filed: April 28, 2021
    Publication date: November 4, 2021
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Glen BANKS, Jonathan Harry DAVIS, Paul Charles LEVESQUE